The Hanover Insurance Group, Inc.
The Hanover Insurance Group, Inc. (THG) Financial Performance & Income Statement Overview
Analyze The Hanover Insurance Group, Inc. (THG) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
The Hanover Insurance Group, Inc. (THG) Income Statement & Financial Overview
Explore comprehensive income reports for The Hanover Insurance Group, Inc. THG, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.60B | $1.58B | $1.56B | $1.54B |
| Cost of Revenue | $1.27B | $1.17B | $1.26B | $1.31B |
| Gross Profit | $326.50M | $406.30M | $299.50M | $224.20M |
| Gross Profit Ratio | $0.20 | $0.26 | $0.19 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $166.40M | $194.80M | $169.80M | $172.90M |
| Total Costs & Expenses | $1.44B | $1.37B | $1.43B | $1.48B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $8.50M | $8.50M | $8.50M | $8.60M |
| Depreciation & Amortization | -$1.10M | -$600000.00 | $500000.00 | $800000.00 |
| EBITDA | $167.50M | $219.40M | $138.70M | $60.70M |
| EBITDA Ratio | $0.10 | $0.14 | $0.09 | $0.04 |
| Operating Income | $168.60M | $220.00M | $138.20M | $59.90M |
| Operating Income Ratio | $0.11 | $0.14 | $0.09 | $0.04 |
| Other Income/Expenses (Net) | -$8.50M | -$8.50M | -$8.50M | -$8.60M |
| Income Before Tax | $160.10M | $211.50M | $129.70M | $51.30M |
| Income Before Tax Ratio | $0.10 | $0.13 | $0.08 | $0.03 |
| Income Tax Expense | $31.90M | $44.20M | $27.60M | $10.90M |
| Net Income | $128.20M | $167.90M | $102.10M | $40.50M |
| Net Income Ratio | $0.08 | $0.11 | $0.07 | $0.03 |
| EPS | $3.57 | $4.68 | $2.84 | $1.13 |
| Diluted EPS | $3.52 | $4.68 | $2.80 | $1.12 |
| Weighted Avg Shares Outstanding | $35.90M | $36.00M | $36.00M | $36.00M |
| Weighted Avg Shares Outstanding (Diluted) | $36.40M | $36.60M | $36.50M | $36.30M |
The company's financials show resilient growth, with revenue advancing from $1.54B in Q2 2024 to $1.60B in Q1 2025. Gross profit remained healthy with margins at 20% in Q1 2025 compared to 15% in Q2 2024. Operating income hit $168.60M last quarter, sustaining a consistent 11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $167.50M. Net income dropped to $128.20M, while earnings per share reached $3.57. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan